Wellcome Trust Centre for Cell-Matrix Research, University of Manchester
Division of Cell Matrix Biology and Regenerative Medicine
Visiting Research Fellow
Chika Ueda, Tomoko Horinouchi, Yuta Inoki, Yuta Ichikawa, Yu Tanaka, Hideaki Kitakado, Atsushi Kondo, Nana Sakakibara, China Nagano, Tomohiko Yamamura, et al. Clinical characteristics and outcomes of immune-complex membranoproliferative glomerulonephritis and C3 glomerulopathy in Japanese children. Pediatric nephrology (Berlin, Germany). 2024
Yuimi Koyama, Mary Ann Suico, Aimi Owaki, Ryoichi Sato, Jun Kuwazuru, Shota Kaseda, Yuya Sannomiya, Jun Horizono, Kohei Omachi, Tomoko Horinouchi, et al. Trimerization profile of type IV collagen COL4A5 exon deletion in X-linked Alport syndrome. Clinical and Experimental Nephrology. 2024
Christine Chew, Oliver J Brand, Tomohiko Yamamura, Craig Lawless, Mychel Raony Paiva Teixeira Morais, Leo Zeef, I-Hsuan Lin, Gareth Howell, Sylvia Lui, Franziska Lausecker, et al. Kidney resident macrophages have distinct subsets and multifunctional roles. Matrix biology : journal of the International Society for Matrix Biology. 2024. 127. 23-37
Alexander Eckersley, Tomohiko Yamamura, Rachel Lennon. Matrikines in kidney ageing and age-related disease. Current opinion in nephrology and hypertension. 2023. 32. 6. 551-558
Ryuichiro Hirayama, Kosuke Toyohara, Kei Watanabe, Takeya Otsuki, Toshikazu Araoka, Shin-Ichi Mae, Tomoko Horinouchi, Tomohiko Yamamura, Keisuke Okita, Akitsu Hotta, et al. iPSC-derived type IV collagen α5-expressing kidney organoids model Alport syndrome. Communications Biology. 2023. 6. 1
Gene therapy for Alport syndrome
(The 18th congress of Asian society of pediatric research 2023)
Exploring the molecular basis of Ramipril-induced nephroprotection in Alport syndrome
(American society of Nephrology Kidney week 2023 2023)
Emerging therapy in Alport syndrome
(European society of pediatric nephrology (ESPN) 55th annual meeting 2023)
Exon skipping therapy for COL4A5 gene truncating variant rescued progression of kidney failure in X-linked Alport syndrome
(ASN Kidney week 2019 2019)
Exon skipping therapy for COL4A5 gene truncating variant rescued progression of kidney failure in X-linked Alport syndrome
(2019 International Workshop on Alport Syndrome 2019)